179 related articles for article (PubMed ID: 15180186)
1. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma.
Linsalata M; Notarnicola M; Caruso MG; Di Leo A; Guerra V; Russo F
Scand J Gastroenterol; 2004 May; 39(5):470-7. PubMed ID: 15180186
[TBL] [Abstract][Full Text] [Related]
2. Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics.
Notarnicola M; Linsalata M; Caruso MG; Caruso ML; Altomare D; Lorusso D; Leo S; Di Leo A
Oncol Rep; 2003; 10(6):1987-91. PubMed ID: 14534731
[TBL] [Abstract][Full Text] [Related]
3. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer.
Linsalata M; Giannini R; Notarnicola M; Cavallini A
BMC Cancer; 2006 Jul; 6():191. PubMed ID: 16854216
[TBL] [Abstract][Full Text] [Related]
5. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
7. Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma.
Russo F; Linsalata M; Giorgio I; Caruso ML; Armentano R; Di Leo A
Dig Dis Sci; 1997 Mar; 42(3):576-9. PubMed ID: 9073141
[TBL] [Abstract][Full Text] [Related]
8. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.
Weiss TS; Bernhardt G; Buschauer A; Thasler WE; Dolgner D; Zirngibl H; Jauch KW
Int J Colorectal Dis; 2002 Nov; 17(6):381-7. PubMed ID: 12355213
[TBL] [Abstract][Full Text] [Related]
9. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
10. K-ras and p53 mutations in colonic lavage fluid of patients with colorectal neoplasias.
Heinzlmann M; Neynaber S; Heldwein W; Folwaczny C
Digestion; 2001; 63(4):229-33. PubMed ID: 11435722
[TBL] [Abstract][Full Text] [Related]
11. [A study on the mutation of P53 and K-ras gene in colorectal adenomas and colorectal carcinomas].
Xu W; Cheng Y; Shen XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):821-6. PubMed ID: 23387205
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
13. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030
[TBL] [Abstract][Full Text] [Related]
14. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
Malhotra P; Anwar M; Nanda N; Kochhar R; Wig JD; Vaiphei K; Mahmood S
Tumour Biol; 2013 Jun; 34(3):1901-11. PubMed ID: 23526092
[TBL] [Abstract][Full Text] [Related]
15. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
16. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Shimada S; Shiomori K; Tashima S; Tsuruta J; Ogawa M
Br J Cancer; 2001 Jun; 84(11):1497-504. PubMed ID: 11384100
[TBL] [Abstract][Full Text] [Related]
17. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
[TBL] [Abstract][Full Text] [Related]
18. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G
J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521
[TBL] [Abstract][Full Text] [Related]
19. [Study of angiogenesis in human colorectal carcinoma and its modulation by p53 and K-ras gene].
Zhong SS; Zhang ZS; Li SM; Deng HJ; Ma Q
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):77-80. PubMed ID: 12783699
[TBL] [Abstract][Full Text] [Related]
20. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
Yamashita K; Yoshida T; Shinoda H; Okayasu I
Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
